Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE).
Daniel J WallaceFlorence FiguerasWilliam A WegenerDavid M GoldenbergPublished in: Annals of the rheumatic diseases (2021)